B abco ck, MD Assistant Professor of Medicine Division of I nfectious Diseases Department of I nternal Medicine Washington University School of Medicine Kath erin e E.. Babco ck, MD Assi
Trang 2THE WASHINGTON MANUAL™
Infectio us Diseases Su bspecial ty Co n su l t
SECO ND EDITIO N
Editors
Nigar Kirman i, MD
Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Keith F W o el tje, MD, Ph D
Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Hil ary M B abco ck, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
Kath erin e E Hen derso n , MD
Assistant Professor of Clinical Medicine
Trang 3Department of Medicine
Washington University School of Medicine
Barnes-Jewish Hospital
St Louis, Missouri
Trang 4Senior Acquisitions Editor: Sonya Seigafuse
Senior Product Manager: Kerry Barrett
Vendor Manager: Alicia Jackson
Senior Marketing Manager: Kimberly Schonberger
Senior Manufacturing Manager: Benjamin Rivera
Editorial Coordinator: Katie Sharp
Design Coordinator: Stephen Druding
Production Service: Integra Software Services Pvt Ltd.
© 2013 by De partme nt of Me dicine , Washington Unive rsity School of Me dicine
Printed in China
All rights reserved This book is protected by copyright No part of this book may be reproduced in any form by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews Materials appearing in this book prepared by individuals as part of their official duties as U.S government employees are not covered by the above-mentioned copyright.
Library of Congress Cataloging-in-Publication Data
The Washington manual infectious diseases subspecialty consult —2nd ed / editors, Nigar Kirmani, Keith F Woeltje, Hilary M Babcock.
p ; cm — (Washington manual subspecialty consult series)
Infectious diseases subspecialty consult
Includes bibliographical references and index.
ISBN 978-1-4511-1364-8 — ISBN 1-4511-1364-1
I Kirmani, Nigar II Woeltje, Keith F III Babcock, Hilary IV Washington University (Saint Louis, Mo.) School of Medicine V Title: Infectious diseases subspecialty consult VI Series: Washington manual subspecialty consult series.
[DNLM: 1 Communicable Diseases—Handbooks 2 Diagnosis, Differential—Handbooks 3 Patient Care Planning—Handbooks WC 39]
616.9—dc23
2012025731
The Washington Manual™ is an intent-to-use mark belonging to Washington University in St Louis to which international legal protection applies The mark is used in this publication by LWW under license from Washington University.
Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in this book and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of the publication Application of the information in a particular situation remains the professional responsibility of the practitioner.
The authors, editors, and publisher have exerted every effort to ensure that drug selection and dosage set forth
in this text are in accordance with current recommendations and practice at the time of publication However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions This is particularly important when the
Trang 5recommended agent is a new or infrequently employed drug.
Some drugs and medical devices presented in the publication have Food and Drug Administration (FDA) clearance for limited use in restricted research settings It is the responsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice.
To purchase additional copies of this book, call our customer service department at (800) 638-3030 or fax orders
to (301) 223-2320 International customers should call (301) 223-2300.
Visit Lippincott Williams & Wilkins on the Internet: at LWW.com Lippincott Williams & Wilkins customer
service representatives are available from 8:30 am to 6 pm, EST.
10 9 8 7 6 5 4 3 2 1
Trang 6Contributing Authors
Hil ary M Babco ck, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Tho mas C Bail ey, MD
Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Erik R Dubberke, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Michael J Durkin , MD
I nstructor in Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Jessica R Grubb, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
Trang 7St Louis, Missouri
José E Hagan , MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Zhuo l in Han , MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Jeffrey P Hen derso n , MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Hito shi Ho n da, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Cyn thia John so n , MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Amel ia M Kasper, MD
Resident
Trang 8Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Nigar Kirman i, MD
Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Robyn S Kl ein , MD
Associate Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
F Matthew Kuhl man n , MD
I nstructor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Michael A Lan e, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Steven J Lawren ce, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Trang 9Susan a Lazarte, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Stephen Y Lian g, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Luis A Marco s, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Jon as Marschal l , MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Jay R McDo n al d, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Dian a Nurutdin o va, MD
I nstructor in Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Trang 10Washington University School of Medicine
St Louis, Missouri
Rachel Presti, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Hil ary Ren o , MD
I nstructor in Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
David J Riddl e, MD
I nstructor in Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
David J Ritchie, PharmD
Clinical Pharmacist, I nfectious Diseases
Barnes-Jewish Hospital
Professor of Pharmacy Practice
St Louis College of Pharmacy
St Louis, Missouri
Carl o s San to s, MD
Assistant Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Mo l l y F Sariko n da, MD
Trang 11Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
To shibumi Tan iguchi, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Bren t W Wiel an d, MD
Clinical Fellow
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Keith F Wo el tje, MD, PhD
Professor of Medicine
Division of I nfectious Diseases
Department of I nternal Medicine
Washington University School of Medicine
St Louis, Missouri
Trang 12Washington Manual Subspecialty Series addresses this challenge by concisely and
practically providing current scientific information for clinicians to aid them in thediagnosis, investigation, and treatment of common medical conditions
I want to personally thank the authors, who include house officers, fellows, andattendings at Washington University School of Medicine and Barnes-JewishHospital Their commitment to patient care and education is unsurpassed, and theirefforts and skill in compiling this manual are evident in the quality of the finalproduct In particular, I would like to acknowledge our editors, Drs Nigar Kirmani,Keith Woeltje, and Hilary Babcock, and the series editors, Drs Tom De Fer andKatherine Henderson, who have worked tirelessly to produce another outstandingedition of this manual I would also like to thank Dr Melvin Blanchard, Chief of theDivision of Medical Education in the Department of Medicine at WashingtonUniversity School of Medicine, for his advice and guidance I believe thisSubspecialty Manual will meet its desired goal of providing practical knowledgethat can be directly applied at the bedside and in outpatient settings to improvepatient care
Victoria J Fraser, MD
Dr J William Campbell ProfessorInterim Chairman of MedicineCodirector of the Infectious Disease DivisionWashington University School of Medicine
Trang 13Infectious disease is an exciting field in constant evolution Even since therelease of the first edition of this manual, there have been new diseases, newdiagnostic methods, and new treatment challenges with the development of multiple-drug–resistant organisms There continues to be a need for specialists in this field.Infectious disease specialists treat patients of all ages, deal with all organ systems,and collaborate with nearly all other medical specialties and subspecialties Ininfectious disease, no case is exactly the same, so there is no “cookbook” approach
to these problems This makes each case intriguing, and even the most mundanecases have appeal It is our hope that this manual stimulates interest in infectiousdisease among its readers and inspires them to pursue a career in this specialty
This manual complements the Washington Manual of Medical Therapeutics by
providing more in-depth coverage of infectious diseases We have focused onproviding easy-to-follow guidance for the diagnosis and treatment of infectiousdiseases likely to be seen by medical house officers and hospitalists Diseases areorganized primarily by organ system to facilitate generating a useful differentialdiagnosis based on a patient’s presentation By providing practical guidance forcommon problems, the manual serves not as a comprehensive textbook, but rather as
a go-to reference that can be kept handy on the wards
It should be noted that the dosing information in the text assumes normal renalfunction unless otherwise indicated Dosing information for impaired renal function
is available in Chapter 20: Antimicrobial Agents
We would like to offer special thanks to Katie Sharp for her extensive assistance
in keeping the project organized and moving forward This book wouldn’t have beenpossible without her We would also like to thank Dr Tom De Fer in the Department
of Medicine for his editorial guidance And finally we’d like to recognize Dr.Victoria Fraser, the J William Campbell Professor in the Department of Medicine.She is an outstanding clinician, researcher, and administrator Initially as a facultymember, then as cochief of the Infectious Diseases Division, and now as Chair ofMedicine, her mentorship has been invaluable Thanks for everything, Vicky, even if
Trang 14it is exhausting trying to keep up with you.
N.K.K.F.W.H.M.B
Trang 15Contributing Authors
Chairman’s Note
Preface
1 Approach to the Infectious Disease Consultation
F Matthew Kuhlmann and Hilary M Babcock
2 The Acute Febrile Patient and Sepsis
Stephen Y Liang and Jay R McDonald
3 Fever of Unknown Origin
Stephen Y Liang and Nigar Kirmani
4 Bacteremia and Infections of the Cardiovascular Systems
Brent W Wieland and Rachel Presti
5 Respiratory Infections
Michael J Durkin, Thomas C Bailey, and Michael A Lane
6 Infections of the Gastrointestinal and Hepatobiliary Tract
Zhuolin Han and Erik R Dubberke
7 Urinary Tract Infections
Amelia M Kasper and Jeffrey P Henderson
8 Infections of the Bone and Joint
Molly F Sarikonda and Jonas Marschall
9 Skin and Soft Tissue Infections
Molly F Sarikonda and David J Riddle
10 Central Nervous System Infections
Susana Lazarte and Robyn S Klein
Trang 1611 Sexually Transmitted Infections
Amelia M Kasper and Hilary Reno
12 Human Immunodeficiency Virus Infection
Toshibumi Taniguchi and Diana Nurutdinova
13 Opportunistic Infections Associated with HIV
Toshibumi Taniguchi and Jessica R Grubb
14 Infection in Non-HIV Immunocompromised Hosts
Cynthia Johnson and Carlos Santos
15 Endemic Mycoses
Brent W Wieland and Keith F Woeltje
16 Zoonotic Infections and Ectoparasites
José E Hagan and Steven J Lawrence
Trang 171 Approach to the Infectious Disease Consultation
F Matthew Kuhl man n an d Hil ary M Babco ckGENERAL PRINCIPLES
The greatest challenge in the infectious disease consultation is the breadth of thesubspecialty Disease manifestations involve all specialties and organ systems.Infectious disease consultation requires thorough evaluation, organized thoughtprocesses, and an ability to appropriately consider rare but significant diagnoses
Four general categories of infectious disease consults
Diagnostic dilemmas are by far the most challenging consultation; they are
classified as consults where a diagnosis remains elusive Types of consultsinclude evaluations for fever of unknown origin and other seemingly mysteriousillnesses Thorough evaluation and history describing details of the patient’spotential exposures is critical
Therapeutic management involves management of a specific infection as it
relates to the overall care of the patient, such as an infected knee implant
Antibiotic management ensures appropriate choice, dose, and duration of
antibiotics for a given infection
Occupational health and infection prevention ensure the health of employees,
patients, and visitors within health care facilities
The ten commandments for effective consultation
Established in 1983 by Goldman and others and modified by Salerno in 2007, thefollowing rules provide a framework for effective patient care and communicationwith requesting physicians.1,2 Knowing the specific expectations of the requestingphysician allows you to address the concerns leading to the consultation Alwaysremember that a physician requests a service from the consultant much like aconsumer buys products from a vendor
Determine your customer Are you providing management for a surgeon or
guidance for an internist? What specific question should be answered?
Establish urgency How quickly should the patient be seen? Several potential
infectious diseases, such as necrotizing fasciitis or cerebral malaria, requireemergent consultation to initiate proper therapy
Look for yourself Although one does not need to repeat every excruciating
detail in written consultation, each important detail should be reconfirmed
Trang 18Be as brief as appropriate Write concise assessments that adequately explain
your rationale
Be specific and humble Write clear plans Provide help in executing the plans
when requested Such help may include order writing or obtaining additionalinformation from hospitals or health departments
Provide contingency plans Determine likely problems and provide guidance
for their remediation Provide around-the-clock contact information in order toassist in addressing such problems when they arise
Determine the appropriate level of management How much should you
intervene regarding order writing and dictating patient care? This should benegotiated with the requesting physician during initial discussions
Teach with tact and pragmatism Provide educational materials or discussions
appropriate to the given situation
Talk is essential Always call the requesting physician with your
recommendations
Follow up daily Daily written notes should be provided until problems are no
longer active as determined by yourself and the requesting physician Provideappropriate long-term follow-up care
“Curbside” consultation
Frequently, requesting physicians ask for opinions based on limited conversation.Such consultations, called “curbside consultations,” are considered a courtesy andpromote collegiality When providing curbside consultation, one should alwaysspeak in general terms and avoid providing absolute recommendations.Frequently, important historical details are unintentionally omitted, limiting theability to provide accurate advice Generalized guidelines for providing curbsideconsultation are provided below
Appropriate for curbside consultation
Dose or duration of antibiotics for simple infections
Choice of antibiotics for simple infections
Inappropriate for curbside consultation
Complex patient problems
Uncertainty regarding question asked by the requesting physician
Infections due to highly resistant organisms, rare organisms, or bloodstreaminfections
Patient concerns
Many patients may feel that additional questioning by a consultant is redundant orinsulting Frequently, a thorough review of the written record followed byempathetic consultations will provide improved rapport with the patient Thefollowing suggestions may be beneficial in alleviating patient fear:
Trang 19Advise patients that you are visiting them on the request of their primaryphysician and that you will work closely with that physician to provide the bestcare possible.
Consider telling the patient that you have reviewed his/her history and haveadditional specific questions that you would like to ask before providing anopinion on his/her care
Ask the patient to confirm your brief understanding of his/her history and tosupplement information with important details After the initial conversation,specific or open-ended questions regarding the history of the patient’s illnesscan be asked
Do not provide information that directly contradicts the clinical care of theprimary provider Reasons for following a specific care plan may not be readilyapparent at the time of the patient encounter and should be clarified with therequesting physician prior to instituting changes
STRUCTURE O F CO NSULT NO TES
Consult notes are written in a fashion similar to the admission history and physical.Details relating to specific sections follow
History of present illness (HPI) The admission HPI provides the structure for
the consultation HPI Provide a thorough review of the patient’s current illness(onset, severity, duration, location, etc.) and hospital course Specific details ofpositive findings or pertinent negative findings from the review of systems, pastmedical/surgical history, family history, and social history should be included
Review of systems A thorough review of systems should be obtained Patients
may forget to include significant history in their initial encounters Such detailsmay provide additional information leading to a diagnosis
Past medical and surgical history
Specific details should be summarized in the HPI, with additional informationsupplemented in the body of the consultation note
Review detailed histories of immunosuppression due to illness or medications Details of surgeries and surgical findings related to infections should besummarized
Pertinent vaccination history can be summarized
Medications
Review histories of any antimicrobial therapy that has been administered in thepast several months Note doses, durations, and any available drug levels
Any immunosuppressive medications should be noted
Note drugs that frequently interact with antimicrobials, especially warfarin
Trang 20Allergies Note not only the drugs, especially antibiotics, but also the type of
reaction (rash vs anaphylaxis, etc.)
Social history This section could be alternatively named exposure history, as
many behaviors place patients at risk for specific infections General topics toreview include the following:
Living environment In what geographical region does the patient reside? Does
the patient live in a stable home or is he/she homeless? Does the patient live in
an urban or rural environment?
Work history Different jobs involve exposures to various infectious or toxic
agents
Animals Specific zoonoses can be diagnosed based on the exposures to certain
domestic or wild animals
Travel history The patient may have traveled to areas that harbor specific
infections, even within their native country Any travel history over a patient’slifetime may be considered important
Sexual history The number of partners places a patient at risk for sexually
transmitted infections, and the nature of such interactions may be important,leading to additional diagnoses, e.g., oropharyngeal gonococcal infections
Physical exam A detailed exam can provide additional clues to the cause of a
patient’s illness or complications from a patient’s medical interventions Rashesare highly indicative of specific infections or toxicities from antibiotics Thoroughdermatological, oral, ocular, and lymph node exams are especially important.Detailed descriptions of infected lesions remain essential
Data
One should review all serological, radiological, and pathological studies andconsider reviewing the data with the microbiologist, radiologist, or pathologist Trends in routine chemistries should be described, as they are much moreinformative than one isolated time point Note the differential on complete bloodcounts as neutropenia and lymphopenia are not evident from the total blood cellcount For patients receiving long-term antibiotics, recent liver function testingshould be noted
Note specific details of microbiological culture data, both positive and negativecultures
Site of collection (e.g., peripheral vs central line, right arm vs left arm,specific drains)
Time of collection
Full susceptibility profiles
All identified microorganisms
Especially note any prior serological data such as viral, fungal, or bacterial
Trang 21antibody titers.
Assessment Summarize the case and describe the rationale for your
recommendations as noted in the ten commandments for effective consultation;communicate your assessment directly to the requesting physician
Plan Outline your recommendations in an easy-to-read format, supplement with
details only if they are not provided in your assessment
REFERENCES
1 Goldman L, Lee T, Rudd P Ten commandments for effective consultations Arch Intern Med.
1983;143:1753-1755.
2 Salerno SM, Hurst FP, Halvorson S, Mercado DL Principles of effective consultation: an update for the
21st-century consultant Arch Intern Med 2007;167:271-275.
Trang 222 The Acute Febrile Patient and Sepsis
Stephen Y Lian g an d Jay R McDo n al dAPPRO ACH TO THE ACU TE FEB RILE PATIENT
GENERAL PRINCIPLES
Defin itio n
Fever has classically been defined as a body temperature of ≥38.0°C (100.4°F).Recent evidence suggests that the upper limit of normal oral temperature may be37.2°C (98.9°F) in the early morning and 37.7°C (99.9°F) overall in healthyadults, though significant variability exists between individuals.1
Febrile response in the elderly patient is frequently blunted, leading some todefine fever in this population as a persistent oral temperature ≥37.2°C (98.9°F),rectal temperature ≥37.5°C (99.5°F), or a rise in temperature of ≥1.3°C (2.3°F)above baseline.2
Oral temperatures are generally 0.4°C (0.7°F) lower than rectal temperatures.Axillary and tympanic temperatures may be unreliable
Etio l o gy
Infectious causes of fever lasting less than 2 weeks are legion and may range fromself-limited viral to serious bacterial infections Differential diagnosis hingesheavily upon the history and physical examination Fevers of unknown originlasting more than 3 weeks are discussed in Chapter 3
Noninfectious causes of fever may include neoplastic, rheumatologic, endocrine,thromboembolic, and medication-related disorders
While hyperpyrexia (>41.5°C or 106.7°F) may be encountered with severeinfection, it is more common with central nervous system hemorrhage
Hyperthermia is a distinct entity apart from fever and may result from
environmental factors, endocrine disorders (hyperthyroidism), and certainmedications (e.g., anesthetics, neuroleptic agents, recreational drugs)
Patho physio l o gy
Thermoregulation is mediated by the hypothalamus
Exogenous pyrogens (e.g., microbes, toxins) induce host macrophages and otherphagocytic cells, triggering the release of endogenous cytokines (e.g., interleukin
Trang 23[IL]-1, IL-6, tumor necrosis factor [TNF]-α, interferons).
These endogenous pyrogens modulate an inflammatory acute phase response andpromote prostaglandin E2 (PGE2) synthesis It is thought that PGE2 acts upon thehypothalamus, precipitating a rise in body temperature
DIAGNO SIS
Cl in ical Presen tatio n
History
Clarify the patient’s definition of “fever,” whether it is subjective, tactile, or
measured, and if so, by what route Characterize the magnitude, duration, andconsistency of the fever
Establish a time line of all symptoms in relation to the start of the fever While
the cause may be obvious in many cases, a thorough review of systems mayuncover additional symptomatology characteristic of specific infections (e.g.,myalgias, rashes, lymphadenopathy) Look for temporal relationships betweenfever and medical interventions (e.g., surgeries, catheters, mechanical ventilation,antibiotics, prolonged hospitalizations)
Ascertain the immune status of the patient Neoplasm, chemotherapy,
immunosuppressive therapy (to prevent transplant rejection or treat rheumatologicdisorders), corticosteroid use, human immunodeficiency virus (HIV) infection, andprimary immunodeficiency disease (e.g., humoral immune or severe combinedimmunodeficiencies) all influence the spectrum of infections possible
Obtain a complete past medical history, surgical history (including all prosthetics,foreign materials, and implantable devices), and medication list (prescription,over-the-counter, alternative) Use of antipyretics should be noted Whenavailable, a vaccination record should be reviewed, particularly in asplenic andimmunocompromised patients
A social history should identify environmental, occupational, recreational, sexual,dietary, animal, and travel exposures as well as sick contacts
Family members can frequently provide additional insight into the patient’s illnessand exposure history
Physical Examination
A thorough and methodical approach to the physical examination helps ensure thatsubtle findings are not missed (see Table 2-1)
Febril e Syn dro mes
When used in conjunction with the history and physical, common febrile
Trang 24syndromes help guide the differential diagnosis by suggesting organ-specificdisease processes.
Fever and headache is concerning for meningitis, while fever with focalneurological deficits or seizure may suggest encephalitis, cerebral abscess,subdural empyema, or epidural abscess
Fever and chest pain mandates a search for pneumonia, but may also be seen withpericarditis, esophagitis, and mediastinitis
Depending on the location and history, fever and abdominal pain may raise thesuspicion of cholecystitis, appendicitis, intra-abdominal abscess, peritonitis,diverticulitis, colitis, or a host of other pathologies
Other febrile syndromes (e.g., rash [Table 2-2], lymphadenopathy [Table 2-3],jaundice, and splenomegaly) may be indicative of an underlying systemic infection(Table 2-4)
TAB LE 2 -1 PHY SICAL EXAMINATION FINDINGS AND CLINICAL SY NDRO MES TO CO NSIDER IN
THE PATIENT W ITH FEVER
Lo catio n Fin din gs an d asso ciatio n s
Eyes Retinitis and other lesions (e.g., Roth spots), uveitis, hypopyon, conjunctival
suffusion/hemorrhage, conjunctivitis, visual field deficits Ears Otitis media/externa, mastoiditis
Face, nose, throat Sinus tenderness, pharyngitis (erythema, exudate), mucosal lesions, thrush, periodontitis,
peritonsillar abscess, muffled voice (epiglottitis)
Neck Neck stiffness (meningitis, retropharyngeal abscess), tenderness along the sternocleidomastoid
muscle (internal jugular septic thrombophlebitis), thyromegaly Heart Murmurs (endocarditis), rubs, distant sounds
Lungs Crackles, rhonchi, wheezes, dullness to percussion
Abdomen Focal tenderness, peritoneal signs, hepatomegaly, splenomegaly, ascites
Genitourinary/rectum Male: urethritis, prostatitis, orchitis, epididymitis
Female: cervicitis, adnexal mass/tenderness, foreign body (e.g., tampon) Rectum: perirectal fluctuance (abscess), ulcers, Fournier gangrene Back Pressure sores, decubitus ulcers, costovertebral angle tenderness
Extremities Stigmata of endocarditis (Osler nodes, Janeway lesions, splinter hemorrhages), clubbing,
palmar/plantar rashes, track marks Neuro Altered mental status, focal neurologic deficits, ataxia
Trang 25Skin Cellulitis, cutaneous abscess, sinus tracts, crepitus, necrotizing soft tissue infection, rash
(petechiae, purpura, macules, papules, vesicles, ulcers, eschars) Musculoskeletal Effusion, septic arthritis, spinous process tenderness
Lymph Any lymphadenopathy, lymph node fluctuance or drainage
Devices Pacemaker/defibrillator, tunneled intravenous catheter, implantable port, orthopedic hardware
Diagn o stic Testin g
Laboratories
Initial testing
Laboratory evaluation of fever should be driven by the nature and severity of thepatient’s symptoms In the inpatient setting, the following tests are a reasonablestarting point to screen for abnormalities:
Complete blood count with differential (leukocytosis, neutrophilia, bandemia,neutropenia, anemia, thrombocytopenia)
Metabolic panel (hyponatremia, acidosis, impaired renal function)
Trang 27Liver tests (transaminitis, cholestasis)
Coagulation studies (disseminated intravascular coagulation)
Urinalysis (urinary tract infection, active urinary sediment)
HIV screening is strongly recommended, particularly in high-prevalence areas
Cultures should be obtained prior to antimicrobials whenever possible.
However, collection of cultures should not delay antimicrobial administration in
an unstable patient
Blood cultures (preferably a minimum of 2 to 3) should be obtained from afebrile patient within the first 24 hours of presentation when endocarditis,bacteremia, or catheter-associated bloodstream infection is suspected Eachculture should consist of 20 to 30 mL of blood drawn from a single site at asingle time point In the case of catheter-associated bloodstream infection, at
Trang 28least one culture should be obtained through the infected catheter Specializedblood culture media may be required to effectively isolate fungi,
mycobacteria, viruses, and rare organisms (e.g., Brucella spp.).
Urine cultures should be obtained if a urinary tract infection is suspected
Sputum and bronchoalveolar lavage cultures may be obtained to guideantibiotic therapy of pneumonia, particularly in intensive care unit (ICU) andseverely immunocompromised patients where fungal and mycobacterialinfections are also suspected
Stool cultures, parasite examination, and tests for Clostridium difficile
infection should be considered in a febrile patient with diarrhea
If osteomyelitis is suspected, an erythrocyte sedimentation rate and C-reactive
Trang 29protein may be helpful if highly elevated.
Subsequent testing
In cases where meningitis or encephalitis is suspected, lumbar puncture should
be performed before the initiation of antibiotics if possible Cerebrospinal fluidshould be sent for cell count, glucose, protein, culture, Gram stain, culture, andother specialized tests based on clinical suspicion
As a general rule, all fluid collections suspected of being infected (e.g., pleuralfluid, ascites, abscess) should be sampled and sent for cell count, culture, andother appropriate analytic studies
Superinfected chronic wounds (e.g., decubitus or diabetic foot ulcers) should bedebrided first and then cultured from the base of the wound Superficial cultures
Trang 30are contaminated with skin flora that may or may not be responsible for theinfection.
Intravascular catheters strongly suspected as sources of infection should beremoved after blood cultures are obtained through the lumen and the catheter tipshould be sent for culture
Throat and nasopharyngeal cultures may help identify viral and streptococcalupper respiratory infections Testing for influenza, particularly inimmunocompromised and elderly patients, should be considered if the season isappropriate or an epidemic is underway
Disease-specific serologies and other specialized laboratory tests (e.g.,polymerase chain reaction [PCR]) may be indicated in the appropriate clinicalcontext
I maging
Chest radiography should be obtained if pulmonary complaints exist
Computed tomography (CT), magnetic resonance imaging, ultrasound, and nuclearstudies may be indicated based on presenting symptoms and clinical suspicion.Consultation with a radiologist regarding the best modality for visualizingpathology (e.g., abscess, osteomyelitis, cerebral disease) can be helpful inavoiding excessive imaging
Echocardiography should be pursued if endocarditis is suspected based on thepresence of a new heart murmur and other clinical criteria
Diagnostic Procedures
Tissue biopsy for pathology, culture, and other specialized testing may be needed
to establish diagnoses of osteomyelitis, disorders associated withlymphadenopathy (e.g., cat scratch disease, toxoplasmosis), and disseminatedinfections (e.g., tuberculosis, atypical mycobacteria, histoplasmosis)
When possible, appropriate cultures should be obtained during any surgicalintervention to treat an infectious complication (e.g., endocarditis, pacemaker leadinfection, graft or hardware infection)
TREATMENT
An timicro bial Therapy
In the outpatient setting, most fevers in healthy adults are associated with transient,self-limited viral infections and are frequently overtreated with antimicrobials
An emphasis should be placed on establishing an infectious etiology for the fever
to guide appropriate antimicrobial coverage
Trang 31Situations warranting empiric antimicrobial therapy before a definitive diagnosiscan be made include the following:
Acute clinical deterioration (e.g., respiratory distress, altered mental status,hemodynamic instability, sepsis)
Immunocompromised state (e.g., HIV, neoplasm, transplant, immunosuppressivetherapy)
Elderly patients (in whom atypical and muted presentations of serious infectionare common)
Choice of empiric antimicrobial should be based upon the type of infectionsuspected (e.g., pneumonia, meningitis, cellulitis), common microorganismsimplicated, concern for multidrug resistance among those organisms, and localantimicrobial susceptibility patterns
An tipyretic Therapy
Antipyretics can be given for symptom relief but they do not alter outcomes Inpatients with cardiovascular or pulmonary disease, antipyretics may reduce some
of the metabolic demands of fever
Nonsteroidal antiinflammatory drugs including acetaminophen, ibuprofen, andaspirin inhibit the synthesis of inflammatory prostaglandins through thecyclooxygenase pathway and trigger other antipyretic pathways, reducinghypothalamus-mediated fever
Corticosteroids also have antipyretic properties but generally are not indicated forfever control alone
External cooling methods including cooling blankets, fans, and water spongingeffect heat loss through conduction, convection, and evaporation, respectively.Rebound hyperthermia may result if antipyretic medications are not used andshivering is not controlled
SPECIAL CO NSIDERATIO NS
Fever in the In ten sive Care Un it
New, unexplained fevers complicate a significant number of ICU admissions andprolonged hospitalizations.3,4 The causes can be wide ranging, underscoring thecomplexity of these patients (Table 2-5)
Trang 32In reviewing the medical history of the ICU patient, a strong emphasis should beplaced on understanding not only the patient’s initial clinical presentation andprimary diagnosis but also the sequence of medical interventions (e.g., newmedications, procedures, surgeries, health care–associated devices, respiratorysupport) that have taken place since admission.
Nursing observations regarding patient hemodynamics, oxygen requirements,tracheal secretions, catheter sites, skin breakdown, wounds, diarrhea, and otherclinically relevant conditions can lend valuable insight into the patient’s hospitalcourse
Health care–associated infections are responsible for a sizable portion of these
fevers
Intravascular catheter–associated bloodstream infection.5 Infection rates
Trang 33differ by type (uncuffed > tunneled > peripheral), location (femoral vein >internal jugular vein > subclavian vein), duration, frequency of manipulation,and method of placement (use of sterile precautions).
At least one blood culture should be obtained through the infected catheter andone culture from a peripheral site by venipuncture
The intravascular catheter in question should be promptly removed and thecatheter tip sent for culture if sepsis, embolic disease, or tunnel infection issuspected
Peripheral intravenous catheters should be changed every 72 hours regardless
of fever
Ventilator-associated pneumonia Infection occurring more than 48 hours after
endotracheal intubation and mechanical ventilation
Chest radiography or CT with evolving infiltrates coupled with clinical cues(increased purulent tracheal secretions and/or oxygen requirement) helpsecure the diagnosis
Bronchoscopy to obtain accurate lower respiratory tract cultures and Gramstains should be considered
Blood cultures and diagnostic thoracentesis of associated pleural effusionsmay also be helpful in identifying a causative organism
Urinary tract infection.6 Risk factors include having an indwelling urethralcatheter, suprapubic catheter, ureteral stent, or nephrostomy
Urinalysis and urine culture should be obtained from the sampling port of thecatheter and never the drainage bag
Infected catheters should be removed promptly if possible
C difficile infection.7 Spectrum of disease may range from diarrhea to ileus andtoxic megacolon Leukemoid reactions with extremely high white blood cellcounts are occasionally seen
Send a stool specimen for C difficile toxin by enzyme immunoassay or PCR
and for fecal leukocytes
Consider empiric therapy with metronidazole or oral vancomycin if illness issevere
Sinusitis Nasotracheal/nasogastric intubations, nasal packing, and maxillofacial
trauma may prevent drainage of the facial sinuses (especially maxillary) leading
Trang 34Wound infection Prolonged or chronic debilitation increases the risk of
pressure sores and decubitus ulcers, which are prone to infection
Examine the back, sacrum, and other dependent areas thoroughly for wounds Document the number, size, and depth of any wounds and any signs ofsuperinfection or necrosis
Transfusion-related infection However rare, bacterial infection may be
transmitted through blood product transfusion Cytomegalovirus (CMV)transmitted by donor leukocytes present in the blood product can precipitate amononucleosis-like syndrome in healthy adults or disseminated disease in theimmunocompromised (particularly if the recipient is CMV seronegative)
Identify the timing of all blood product transfusions in relation to onset offever If a bacterial infection is suspected, obtain a recipient blood culturefrom a site opposite that of the transfusion and culture the donor bloodproduct
Administer leukocyte-reduced blood components to immunocompromisedpatients to prevent CMV disease
Noninfectious causes of a new, unexplained fever in the ICU include the
following:
Drug fever Antimicrobials (e.g., sulfonamides, penicillins, cephalosporins,
vancomycin, nitrofurantoin), anticonvulsants (e.g., phenytoin, carbamazepine,barbiturates), H1- and H2-blocking antihistamines, antihypertensives (e.g.,hydralazine, methyldopa), and antiarrhythmics (e.g., quinidine, procainamide)are common offenders Relative bradycardia, rash, leukocytosis, andeosinophilia may or may not be present
Establish a time line of start and stop dates for all suspect medications(particularly antimicrobials)
The time between discontinuation of the offending agent and resolution offever can be variable and up to a week
Thromboembolic disease Deep vein thrombosis and pulmonary embolus
occasionally present with isolated fever
Endocrine disease Adrenal insufficiency and thyroid storm may present with
fever, tachycardia, and hypotension that can be easily mistaken for sepsis
Transfusion reactions
Febrile nonhemolytic transfusion reactions are common (1 in 100 units)
and occur when recipient antibodies react against antigens on donorleukocytes and platelets, triggering cytokine release anywhere from 30minutes to several hours after a transfusion
Acute hemolytic transfusion reactions result from ABO mismatch and occurwhen preformed recipient antibodies rapidly destroy donor erythrocytes
Trang 35leading to fever, flank pain, and hemoglobinuria This is considered a medicalemergency.
Recent guidelines suggest that a body temperature of ≥38.3°C (100.9°F) or <36°C(96.8°F) is a reasonable threshold for initiating an evaluation for infection in theICU patient Remember that critically ill patients with serious infection may benormothermic or hypothermic in the context of extensive burns, open abdominalwounds, continuous renal replacement therapy, extracorporeal membraneoxygenation, or a host of medical illnesses (e.g., congestive heart failure, end-stage liver or renal disease, myxedema coma) Evaluation for infection should beguided ultimately by clinical suspicion
If infection is suspected, empiric antimicrobial therapy should be initiatedimmediately after appropriate cultures have been obtained The risk of infectionwith multidrug-resistant pathogens should be taken into account along with localantimicrobial susceptibility patterns
Po sto perative Fever
Fever within the first 72 hours after surgery is common and generally
self-limited Cytokine release from surgical trauma is thought to play a part
Wound infections are uncommon during the first three postoperative days.
When an early infection is evident, myonecrosis secondary to Clostridium
species and group A streptococci must be considered and may requireantibiotics and emergent surgical debridement Toxic shock syndrome may
accompany serious infection with group A streptococci or Staphylococcus aureus.
Noninfectious causes of fever may include thromboembolism, hematoma,transfusion reactions, and adrenal insufficiency Malignant hyperthermia maymanifest as muscle rigidity, tachycardia, and hyperthermia up to 10 hours afterinduction of general anesthesia
Fever more than 72 hours after surgery is significant and more likely to be
associated with infection
Wound infections, intra-abdominal infections, abscesses, infected hematomas,and the sequelae of anastomotic leaks are typically seen around the fourth orfifth day after surgery
Health care–associated infections including pneumonia, urinary tract infection(in the setting of urinary catheterization), intravenous catheter–related infections
(cellulitis, thrombophlebitis, bloodstream infection), and C difficile infection
related to antibiotic exposure are also more common
Acalculous cholecystitis, pancreatitis, and thromboembolism are noninfectiousetiologies that must also be considered
Trang 36Postoperative fever may also result from surgical site inflammation, seroma, orhematoma without infection.
Classic teaching maintains that the differential diagnosis of postoperative fever
should focus on the “five Ws”: wind (pneumonia), water (urinary tract infection),
wound, walking (thromboembolism), and “wonder” drugs (medication reaction).
Opinions differ on whether atelectasis causes fever
History gathering should focus on understanding the preoperative presentation(including existing infection), surgical procedure (duration, complexity, bloodproducts, perioperative prophylactic antibiotics, complications including intra-operative contamination; Table 2-6), and postoperative course (cough, diarrhea,pain, and changes in character or volume of surgical drain output or wounddrainage) Hardware and foreign material inserted during the surgery should bedocumented The possibility of drug fever should be examined through achronology of all medications (e.g., antibiotics, anesthetics) received during andafter surgery
Chest radiography, urinalysis, and urine culture are suggested for the evaluation offever presenting more than 72 hours after surgery and for any febrile postoperativepatient who has had a urinary catheter in place for ≥72 hours Hemodynamicinstability with concern for bacteremia or pending sepsis should prompt bloodcultures
All surgical wounds should be examined daily for erythema, induration, andpurulent discharge Surgical and percutaneous drain reservoirs and their exit sitesshould likewise be inspected for evidence of infection
All infected surgical wounds should be cultured and in many cases opened tofacilitate drainage
Superficial wound cultures are seldom helpful in the absence of a clinically
apparent infection.
If an abscess or deep infection is suspected, be aggressive about obtaining furtherimaging and surgical evaluation to determine whether operative or radiology-guided drainage is necessary All fluid collections requiring drainage should besent for culture
Trang 37Be vigilant of intravenous catheter–associated infections, C difficile infection,
and noninfectious causes of fever already discussed with fever in the ICU patient Empiric antimicrobial therapy is generally unnecessary for fever presenting withinthe first 72 hours of surgery, unless infection is clinically evident or uncovered onlaboratory evaluation or imaging Continuation of perioperative prophylacticantibiotics for early postoperative fever does not prevent infection and likelyselects for resistant organisms
Fever in the Immun o co mpro mised Patien t
Immunocompromised patients are at heightened risk not only for acquired infections but also for an extensive range of opportunistic infections Atypical and nonspecific clinical presentations abound Muted inflammatoryresponses arising from neutropenia, corticosteroids, and other forms of
Trang 38community-immunosuppressive therapy may conceal serious infections.
The medical history should assess the severity of the patient’simmunocompromised state and risk factors for primary infection or reactivation oflatent disease (Table 2-7)
The etiology of fever in the immunocompromised patient varies depending uponthe underlying disease and its subsequent therapy Markers of immune status andapproximately derived windows of susceptibility to infection help inform thedifferential diagnosis
In addition to the opportunistic infections discussed below, it is important to keep
in mind that immunocompromised patients are also at risk for common acquired infections (e.g., bacterial pneumonia, influenza) as well as health care–associated infections (e.g., intravascular catheter–associated bloodstream
community-infection, C difficile infection), given their frequent contact with the hospital
environment and exposure to antimicrobials either as chemoprophylaxis or to treatactive infection
TAB LE 2 -7 KEY ASPECTS O F THE MEDICAL HISTO RY IN EVALU ATING THE
IMMU NO CO MPRO MISED PATIENT W ITH FEVER All immunocompromised patients • Any history of tuberculosis
• Chronic infections (e.g., hepatitis B and C)
• Disseminated infections (e.g., mycobacteria, endemic mycoses)
• Opportunistic infections (e.g., Pneumocystis jiroveci, Cryptococcus neoformans, Toxoplasma gondii, Mycobacterium avium complex)
• Chemoprophylaxis against opportunistic infections (dose, duration)
• Baseline serologies (e.g., CMV, T gondii)
• Known colonization with multidrug-resistant organisms
• Presence of long-term intravascular access (tunneled catheters vs.
implantable ports)
• Sick contacts
• Environmental exposures
HI V infection • CD4+ cell count and HI V viral load
• Antiretroviral therapy (date started, adherence)
• Recent unprotected sex
• Presence of immune reconstitution inflammatory syndrome
Trang 39Chemotherapy-related neutropenia • Type and location of neoplasm (solid organ vs hematologic)
• Chemotherapy (dose, duration, number of days since last cycle)
• Other therapies (e.g., surgery, radiation) and any associated complications
• Relapse vs remission of disease Solid organ transplantation • Date and type of organ transplant
• I mmediate and delayed surgical complications associated with transplant
• I mmunosuppressive regimens (dose, duration, serum levels)
• Presence of graft rejection
• Donor and recipient CMV serology Hematopoietic stem cell transplantation • Date and type of transplant (allogeneic vs autologous)
• I mmunosuppressive regimen (dose, duration)
• Presence of GVHD
• Donor CMV serology (if allogeneic transplant)
CMV, cytomegalovirus; HI V, human immunodeficiency virus; GVHD, graft versus host disease.
Trang 40Human immunodeficiency virus
The CD4+ lymphocyte cell count is a reasonably accurate gauge ofsusceptibility to opportunistic infections in the HIV patient (Table 2-8)
Patients recently started on antiretroviral therapy may present with immunereconstitution inflammatory syndrome, an inflammatory immune responseagainst pathogens that may have previously been clinically silent (e.g.,
mycobacteria, Pneumocystis jiroveci, endemic fungi, CMV).
Noninfectious causes of fever particular to HIV include neoplasm (non–Hodgkin lymphoma and occasionally visceral Kaposi sarcoma), drug fever(e.g., trimethoprim–sulfamethoxazole, dapsone), hypersensitivity reaction(abacavir, nevirapine, efavirenz), and Castleman disease (angiofollicularlymph node hyperplasia)